featured
Trastuzumab Emtansine (T-DM1), Paclitaxel, and Pertuzumab in HER2-Positive Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Breast Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase 1b/2a Study of Trastuzumab Emtansine (T-DM1), Paclitaxel, and Pertuzumab in HER2-Positive Metastatic Breast Cancer
Breast Cancer Res 2016 May 01;18(1)34, IE Krop, S Modi, PM LoRusso, M Pegram, E Guardino, B Althaus, D Lu, A Strasak, A EliasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.